Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14)

American Journal of Pathology

Volumn 156, Issue 5, 2000, Pages 1505-1513

  Pruneri, Giancarlo ^a,b   Fabris, Sonia ^a   Baldini, Luca ^a   Carboni, Nadia ^b   Zagano, Savina ^a   Angela Colombi, Maria ^a   Ciceri, Gabriella ^a   Lombardi, Luigia ^a   Rocchi, Mariano ^c   Buffa, Roberto ^b   Teresa Maiolo, Anna ^a   Neri, Antonino ^a  

^a Laboratorio di Ematologia Sperimentale e Genetica Molecolare   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ADULT; AGED; ARTICLE; CHROMOSOME 11; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MARKER GENE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 0033838792     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65022-5     Document Type: Article

References (43)

1. Multiple myeloma: Increasing evidence for a multistep transformation process
2. Cygenetic studies of patients with monoclonal gammopathies
3. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma
4. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization
5. A novel chromosomal translocation t(4:14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene
6. High incidence of translocations t(11;14)(q13;q32) and t(4:14)(p16:q32) in patients with plasma cell malignancies
7. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines
8. Molecular analysis of 11q13 breakpoints in multiple myeloma
9. Frequent translocation t(4:14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
10. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization
11. The t(4; 14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts
12. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an lg locus in multiple myeloma
13. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
14. Molecular cloning of chromosomal breakpoints of B-cell lymphomas and leukemias with the t(11;14) chromosomal translocation
15. Rearrangement of the chromosome 11 bcl.1 locus in centrocytic lymphoma: Analysis with multiple breakpoint probes
16. Detection of 11q13 rearrangements in hematologic neoplasias by double color fluorescence in situ hybridization
17. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization
18. A novel cyclin encoded by a bcl-1 linked candidate oncogene
19. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11:14)(q13:q32) translocation
20. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma
21. Expanded range of 11 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies
22. Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma
23. The t(11;14)(q13;q32) in multiple myeloma cell fine KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene
24. Cyclin D1 expression in non-Hodgkin's lymphomas: Detection by immunohistochemistry
25. Cyclin D1 protein in multiple myeloma and pfasmacytoma: An immunohistochemical study using fixed, paraffin-embedded tissue sections
26. Expression of PRAD1/cyclin D1 in plasma cell malignancy: Incidence and prognostic aspects
27. A clinical staging system for multiple myeloma
28. Histologic classification and staging of multiple myeloma: A retrospective and prospective study of 674 cases
29. Use of avidin-biotin-peroxidase complex (ABC): A comparison between ABC and unlabeled antibody (PAP) procedures
30. Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas
31. High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones
32. Framework Yac contig anchored into a 3.2-Mb high-resolution physical map in proximal 11q13
33. Detailed map of a region commonly amplified at 11q13-q14 in human breast carcinoma
34. Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization
35. Incidence of chromosome numerical changes in multiple myeloma. Fluorescence in situ hybridization analysis using 15 chromosome-specific probes
36. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell
37. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas
38. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia
39. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to proliferation activity
40. Multiple myeloma and the translocation t(11;14)(q13;q32): A report on 13 cases
41. Cytogenetics in multiple myeloma: A multicentric study of 24 patients with t(11;14)(q13;q32) or its variant
42. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities